Literature DB >> 2649131

CA125 in ovarian tumour tissue at second laparotomy.

T S Maughan1, R G Fish, M D Shelley, B Jasani, G T Williams, M Adams.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2649131      PMCID： PMC2247003          DOI： 10.1038/bjc.1989.54

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  12 in total

1.  Explanation of the limited correlation between tumor CA 125 content and serum CA 125 antigen levels in patients with ovarian tumors.

Authors:  G J Fleuren; M Nap; J G Aalders; J B Trimbos; H W de Bruijn
Journal:  Cancer       Date:  1987-11-15       Impact factor: 6.860

2.  The clinical value of serum CA125 levels in ovarian cancer patients receiving platinum therapy.

Authors:  R G Fish; M D Shelley; T Maughan; I Rocker; M Adams
Journal:  Eur J Cancer Clin Oncol       Date:  1987-06

3.  The interpretation of marker protein assays: a critical appraisal in clinical studies and a xenograft model.

Authors:  D Raghavan; J Gibbs; R Nogueira Costa; J Kohn; A H Orr; A Barrett; M J Peckham
Journal:  Br J Cancer Suppl       Date:  1980-04

4.  Predictive value of CA 125 antigen levels in second-look procedures for ovarian cancer.

Authors:  J M Niloff; R C Bast; E M Schaetzl; R C Knapp
Journal:  Am J Obstet Gynecol       Date:  1985-04-01       Impact factor: 8.661

5.  The value of tumour marker CA 125 in surgical pathology.

Authors:  I A Koelma; M Nap; C J Rodenburg; G J Fleuren
Journal:  Histopathology       Date:  1987-03       Impact factor: 5.087

6.  Immunopathologic characterization of a monoclonal antibody that recognizes common surface antigens of human ovarian tumors of serous, endometrioid, and clear cell types.

Authors:  S E Kabawat; R C Bast; W R Welch; R C Knapp; R B Colvin
Journal:  Am J Clin Pathol       Date:  1983-01       Impact factor: 2.493

7.  Antigen CA125 in tumor tissue and serum from patients with adenocarcinoma of the ovary.

Authors:  T S Maughan; R G Fish; M Shelley; B Jasani; G T Williams; M Adams
Journal:  Gynecol Oncol       Date:  1988-07       Impact factor: 5.482

8.  A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer.

Authors:  R C Bast; T L Klug; E St John; E Jenison; J M Niloff; H Lazarus; R S Berkowitz; T Leavitt; C T Griffiths; L Parker; V R Zurawski; R C Knapp
Journal:  N Engl J Med       Date:  1983-10-13       Impact factor: 91.245

9.  CA125 as a serum marker for poor prognosis in ovarian malignancies.

Authors:  R D Alvarez; A To; L R Boots; H M Shingleton; K D Hatch; J Hubbard; S J Soong; M E Potter
Journal:  Gynecol Oncol       Date:  1987-03       Impact factor: 5.482

10.  Ovarian cancer antigen CA125: a prospective clinical assessment of its role as a tumour marker.

Authors:  P A Canney; M Moore; P M Wilkinson; R D James
Journal:  Br J Cancer       Date:  1984-12       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.